Skip to content

Neuropathic pain in head and neck cancer patients referred to Specialist Palliative Care services

Neuropathic pain in head and neck cancer patients referred to Specialist Palliative Care services: a cross sectional observational study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/08/020636
Enrollment
300
Registered
2019-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with head and neck cancer on disease modifying treatment with palliative intent or best supportive care, referred to Department of Palliative Medicine, Tata Memorial Hospital. 2. Age >=18 years. 3. Outpatients and inpatients. 4. Able to give informed consent. 5. Patients able to understand English, Hindi and Marathi. 6. Able to answer and complete questionnaire.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from an intellectual disability or cognitive disorders. 2. Patients with unstable medical/psychiatric disorders needing emergency management. 3. Patients with communication problems. 4. Patients receiving treatment from pain services.

Design outcomes

Primary

MeasureTime frame
â?¢ Prevalence of neuropathic pain in H&N cancer patients referred to specialist Palliative Care servicesâ?? as measured by DN4 tool.Timepoint: 6-9 month

Secondary

MeasureTime frame
1.To measure correlation of neuropathic pain with depression in H&N cancer patients referred to Specialist Palliative Care service. 2.To measure correlation of neuropathic pain with quality of life inH&N cancer patientsreferred to Specialist Palliative Care service. 3.To examine factors associated with NPP in H&N cancer patients. 4.To determine the number of patients having nociceptive and mixed pain.Timepoint: 6-9 month

Countries

India

Contacts

Public ContactDr Pallavi Singh

Tata Memorial Hospital

jukd2000@yahoo.co.uk022241770004271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026